Endothelial progenitor cells and integrins: Adhesive needs

Fibrogenesis and Tissue Repair

Volumn 5, Issue 1, 2012, Pages

  Caiado, Francisco ^a,b,c   Dias, Sérgio ^a,b,c  

^a INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

^b INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

^c UNIVERSITY OF LISBON   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4 INTEGRIN; BETA3 INTEGRIN; CD133 ANTIGEN; CD34 ANTIGEN; INTEGRIN; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; CELL ACTIVITY; CELL ADHESION; CELL COMPARTMENTALIZATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL HOMING; CELL INTERACTION; CELL INVASION; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CELL SURVIVAL; CYTOLOGY; ENDOTHELIAL PROGENITOR CELL; EXTRACELLULAR MATRIX; HEMATOPOIETIC STEM CELL; HUMAN; MOLECULAR BIOLOGY; NONHUMAN; POSTNATAL DEVELOPMENT; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW; STEM CELL MOBILIZATION; TARGET CELL; TISSUE BLOOD FLOW; TISSUE REGENERATION; TISSUE REPAIR; TISSUE SPECIFICITY; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION;

EID: 84859621920     PISSN: None     EISSN: 17551536     Source Type: Journal    
DOI: 10.1186/1755-1536-5-4     Document Type: Review

References (126)

1. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003, 9:653-660. 10.1038/nm0603-653, 12778163.
2. Patan S. Vasculogenesis and angiogenesis as mechanisms of vascular network formation, growth and remodeling. J Neurooncol 2000, 50:1-15. 10.1023/A:1006493130855, 11245270.
3. Hueper WC, Russel MA. Capillary-like formations in tissue culture of leukocytes. Arch Exp Zellforsch 1932, 12:407-424.
4. Parker RC. The development of organized vessels in cultures of blood cells. Science 1933, 2005:544-546.
5. White JF, Parshley MS. Growth in vitro of blood vessels from bone marrow of adult chickens. Am J Anat 1951, 89:321-345. 10.1002/aja.1000890206, 14894443.
6. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-966. 10.1126/science.275.5302.964, 9020076.
7. Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, Ishida A, Fujita Y, Kothari S, Mohle R, Sauvage LR, Moore MA, Storb RF, Hammond WP. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998, 92:362-367.
8. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moore MA, Rafii S. Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood 2000, 95:952-958.
9. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999, 85:221-228.
10. Young PP, Hofling AA, Sands MS. VEGF increases engraftment of bone marrow-derived endothelial progenitor cells (EPCs) into vasculature of newborn murine recipients. PNAS 2002, 99:11951-11956. 10.1073/pnas.182215799, 129375, 12195016.
11. Vaughan EE, Liew A, Mashayekhi K, Dockery P, McDermott J, Kealy B, Flynn A, Duffy A, O'Regan CC, Barry FP, O'Brien T. Pre-treatment of endothelial progenitor cells with osteopontin enhances cell therapy for peripheral vascular disease. Cell Transplant 2012,
12. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, Li T, Isner JM, Asahara T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. PNAS 2000, 97:3422-3427. 10.1073/pnas.070046397, 16255, 10725398.
13. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, Homma S, Edwards NM, Itescu S. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001, 7:430-436. 10.1038/86498, 11283669.
14. Fan Y, Shen F, Frenzel T, Zhu W, Ye J, Liu J, Chen Y, Su H, Young WL, Yang GY. Endothelial progenitor cell transplantation improves long-term stroke outcome in mice. Ann Neurol 2010, 67(4):488-497. 10.1002/ana.21919, 3026588, 20437584.
15. Otani A, Kinder K, Ewalt K, Otero FJ, Schimmel P, Friedlander M. Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis. Nat Med 2002, 8:1004-1010. 10.1038/nm744, 12145646.
16. Mathews V, Hanson PT, Ford E, Fujita J, Polonsky KS, Graubert TA. Recruitment of bone marrow-derived endothelial cells to sites of pancreatic beta-cell injury. Diabetes 2004, 53:91-98.
17. Bauer SM, Goldstein LJ, Bauer RJ, Chen H, Putt M, Velazquez OC. The bone marrow-derived endothelial progenitor cell response is impaired in delayed wound healing from ischemia. J Vasc Surg 2006, 43:134-141. 10.1016/j.jvs.2005.08.038, 16414400.
18. Nakamura T, Torimura T, Sakamoto M, Hashimoto O, Taniguchi E, Inoue K, Sakata R, Kumashiro R, Murohara T, Ueno T, Sata M. Significance and therapeutic potential of endothelial progenitor cell transplantation in a cirrhotic liver rat model. Gastroenterology 2007, 133:91-107. 10.1053/j.gastro.2007.03.110, 17631135.
19. Liu X, Li Y, Liu Y, Luo Y, Wang D, Annex BH, Goldschmidt-Clermont PJ. Endothelial progenitor cells (EPCs) mobilized and activated by neurotrophic factors may contribute to pathologic neovascularization in diabetic retinopathy. Am J Pathol 2010, 176:504-515. 10.2353/ajpath.2010.081152, 2797908, 19948824.
20. Torsney E, Mandal K, Halliday A, Jahangiri M, Xu Q. Characterization of progenitor cells in human atherosclerotic vessels. Atherosclerosis 2007, 191:259-264. 10.1016/j.atherosclerosis.2006.05.033, 16787646.
21. Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, Chadburn A, Heissig B, Marks W, Witte L, Wu Y, Hicklin D, Zhu Z, Hackett NR, Crystal RG, Moore MA, Hajjar KA, Manova K, Benezra R, Rafii S. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001, 7:1194-1201. 10.1038/nm1101-1194, 11689883.
22. Li H, Gerald WL, Benezra R. Utilization of bone marrow-derived endothelial cell precursors in spontaneous prostate tumors varies with tumor grade. Cancer Res 2004, 64:6137-6143. 10.1158/0008-5472.CAN-04-1287, 15342397.
23. Duda DG, Cohen KS, Kozin SV, Perentes JY, Fukumura D, Scadden DT, Jain RK. Evidence for incorporation of bone marrow-derived endothelial cells into perfused blood vessels in tumors. Blood 2006, 107:2774-2776. 10.1182/blood-2005-08-3210, 1895376, 16339405.
24. Gao D, Nolan DJ, Mellick AS, Bambino K, McDonnell K, Mittal V. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 2008, 319:195-198. 10.1126/science.1150224, 18187653.
25. Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 2003, 9:702-712. 10.1038/nm0603-702, 12778169.
26. Urbich C, Dimmeler S. Endothelial progenitor cells: functional characterization. Trends Cardiovascr Med 2004, 14:318-322.
27. Timmermans F, Plum J, Yöder MC, Ingram DA, Vandekerckhove B, Case J. Endothelial progenitor cells: identity defined?. J Cell Mol Med 2009, 13:87-102.
28. Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004, 95:343-353. 10.1161/01.RES.0000137877.89448.78, 15321944.
29. Harrison JS, Rameshwar P, Chang V, Bandari P. Oxygen saturation in the bone marrow of healthy volunteers. Blood 2002, 99:394. 10.1182/blood.V99.1.394, 11783438.
30. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP, Gurtner GC. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004, 10:858-864. 10.1038/nm1075, 15235597.
31. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999, 399:601-605. 10.1038/21224, 10376603.
32. Aicher A, Heeschen C, Mildner-Rihm C, Urbich C, Ihling C, Technau-Ihling K, Zeiher AM, Dimmeler S. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 2003, 9:1370-1376. 10.1038/nm948, 14556003.
33. Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett NR, Crystal RG, Besmer P, Lyden D, Moore MA, Werb Z, Rafii S. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002, 109:625-637. 10.1016/S0092-8674(02)00754-7, 2826110, 12062105.
34. Yamaguchi J, Kusano KF, Masuo O, Kawamoto A, Silver M, Murasawa S, Bosch-Marce M, Masuda H, Losordo DW, Isner JM, Asahara T. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003, 107:1322-1328. 10.1161/01.CIR.0000055313.77510.22, 12628955.
35. De Falco E, Porcelli D, Torella AR, Straino S, Iachininoto MG, Orlandi A, Truffa S, Biglioli P, Napolitano M, Capogrossi MC, Pesce M. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 2004, 104:3472-3482. 10.1182/blood-2003-12-4423, 15284120.
36. Chen L, Wu F, Xia WH, Zhang YY, Xu SY, Cheng F, Liu X, Zhang XY, Wang SM, Tao J. CXCR4 gene transfer contributes to in vivo reendothelialization capacity of endothelial progenitor cells. Cardiovas Res 2004, 88:462-470.
37. Kocher AA, Schuster MD, Bonaros N, Lietz K, Xiang G, Martens TP, Kurlansky PA, Sondermeijer H, Witkowski P, Boyle A, Homma S, Wang SF, Itescu S. Myocardial homing and neovascularization by human bone marrow angioblasts is regulated by IL-8/Gro CXC chemokines. J Mol Cell Cardiol 2006, 40:455-464. 10.1016/j.yjmcc.2005.11.013, 16438981.
38. Spring H, Schüler T, Arnold B, Hämmerling GJ, Ganss R. Chemokines direct endothelial progenitors into tumor neovessels. PNAS 2005, 102:18111-18116. 10.1073/pnas.0507158102, 1312396, 16326806.
39. Jones CP, Pitchford SC, Lloyd CM, Rankin SM. CXCR2 mediates the recruitment of endothelial progenitor cells during allergic airways remodeling. Stem Cells 2009, 27:3074-3081.
40. Huang PH, Chen YH, Wang CH, Chen JS, Tsai HY, Lin FY, Lo WY, Wu TC, Sata M, Chen JW, Lin SJ. Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor cells. Arterioscler Thromb Vasc Bio 2009, 29:1179-1184.
41. Urbich C, Heeschen C, Aicher A, Sasaki K, Bruhl T, Farhadi MR, Vajkoczy P, Hofmann WK, Peters C, Pennacchio LA, Abolmaali ND, Chavakis E, Reinheckel T, Zeiher AM, Dimmeler S. Cathepsin L is required for endothelial progenitor cell-induced neovascularization. Nat Med 2005, 11:206-213. 10.1038/nm1182, 15665831.
42. Basire A, Sabatier F, Ravet S, Lamy E, Mialhe A, Zabouo G, Paul P, Gurewich V, Sampol J, Dignat-George F. High urokinase expression contributes to the angiogenic properties of endothelial cells derived from circulating progenitors. Thromb Haemost 2006, 95:678-688.
43. Igreja C, Fragoso R, Caiado F, Clode N, Henriques A, Camargo L, Reis EM, Dias S. Detailed molecular characterization of cord blood-derived endothelial progenitors. Exp Hematol 2008, 36:193-203.
44. Wijelath ES, Rahman S, Murray J, Patel Y, Savidge G, Sobel M. Fibronectin promotes VEGF-induced CD34+ cell differentiation into endothelial cells. J Vasc Surg 2004, 39:655-660. 10.1016/j.jvs.2003.10.042, 14981463.
45. Hildbrand P, Cirulli V, Prinsen RC, Smith KA, Torbett BE, Salomon DR, Crisa L. The role of angiopoietins in the development of endothelial cells from cord blood CD34+ progenitors. Blood 2004, 104:2010-2019. 10.1182/blood-2003-12-4219, 15213103.
46. Rössig L, Urbich C, Brühl T, Dernbach E, Heeschen C, Chavakis E, Sasaki K, Aicher D, Diehl F, Seeger F, Potente M, Aicher A, Zanetta L, Dejana E, Zeiher AM, Dimmeler S. Histone deacetylase activity is essential for the expression of HoxA9 and for endothelial commitment of progenitor cells. J Exp Med 2005, 201:1825-1835. 10.1084/jem.20042097, 2213253, 15928198.
47. Urbich C, Aicher A, Heeschen C, Dernbach E, Hofmann WK, Zeiher AM, Dimmeler S. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol 2005, 39:733-742. 10.1016/j.yjmcc.2005.07.003, 16199052.
48. Suh W, Kim KL, Kim JM, Shin IS, Lee YS, Lee JY, Jang HS, Lee JS, Byun J, Choi JH, Jeon ES, Kim DK. Transplantation of endothelial progenitor cells accelerates dermal wound healing with increased recruitment of monocytes/macrophages and neovascularization. Stem Cells 2005, 23:571-1578.
49. Hynes RO. The extracellular matrix: not just pretty fibrils. Science 2009, 326:1216-1219. 10.1126/science.1176009, 19965464.
50. Jarvelainen H, Sainio A, Koulu M, Wight TN, Penttinen R. Extracellular matrix molecules: potential targets in pharmacotherapy. Pharmacol Rev 2009, 61:198-223. 10.1124/pr.109.001289, 2830117, 19549927.
51. Schaefer L, Schaefer RM. Proteoglycans: from structural compounds to signaling molecules. Cell Tissue Res 2010, 339:237-246. 10.1007/s00441-009-0821-y, 19513755.
52. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 2002, 110:673-687. 10.1016/S0092-8674(02)00971-6, 12297042.
53. Deb A, Skelding KA, Wang S, Reeder M, Simper D, Caplice NM. Integrin profile and in vivo homing of human smooth muscle progenitor cells. Circulation 2004, 110:2673-2677. 10.1161/01.CIR.0000139842.15651.B2, 15313945.
54. Caiado F, Carvalho T, Silva F, Castro C, Clode N, Dye JF, Dias S. The role of fibrin E on the modulation of endothelial progenitors adhesion, differentiation and angiogenic growth factor production and the promotion of wound healing. Biomaterials 2011, 32:7096-7105. 10.1016/j.biomaterials.2011.06.022, 21741704.
55. Caiado F, Real C, Carvalho T, Dias S. Notch pathway modulation on bone marrow-derived vascular precursor cells regulates their angiogenic and wound healing potential. PLos One 2008, 3:e3752. 10.1371/journal.pone.0003752, 2582964, 19015735.
56. Hibbert B, Ma X, Pourdjabbar A, Holm E, Rayner K, Chen YX, Sun J, Filion L, O'Brien ER. Inhibition of endothelial progenitor cell glycogen synthase kinase-3beta results in attenuated neointima formation and enhanced re-endothelialization after arterial injury. Cardiovasc Res 2009, 83:16-23. 10.1093/cvr/cvp156, 19454488.
57. Angelos MG, Brown MA, Satterwhite LL, Levering VW, Shaked NT, Truskey GA. Dynamic adhesion of umbilical cord blood endothelial progenitor cells under laminar shear stress. Biophys J 2010, 99:3545-3554. 10.1016/j.bpj.2010.10.004, 2998604, 21112278.
58. Bouvard C, Gafsou B, Dizier B, Galy-Fauroux I, Lokajczyk A, Boisson-Vidal C, Fischer AM, Helley D. Alpha6-integrin subunit plays a major role in the proangiogenic properties of endothelial progenitor cells. Arterioscler Thromb Vas Biol 2010, 30:1569-1575.
59. Walter DH, Rittig K, Bahlmann FH, Kirchmair R, Silver M, Murayama T, Nishimura H, Losordo DW, Asahara T, Isner JM. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 2002, 105:3017-3024. 10.1161/01.CIR.0000018166.84319.55, 12081997.
60. Schroeter MR, Leifheit M, Sudholt P, Heida NM, Dellas C, Rohm I, Alves F, Zientkowska M, Rafail S, Puls M, Hasenfuss G, Konstantinides S, Schäfer K. Leptin enhances the recruitment of endothelial progenitor cells into neointimal lesions after vascular injury by promoting integrin-mediated adhesion. Circ Res 2008, 103:536-544. 10.1161/CIRCRESAHA.107.169375, 18658052.
61. Chavakis E, Aicher A, Heeschen C, Sasaki K, Kaiser R, El Makhfi N, Urbich C, Peters T, Scharffetter-Kochanek K, Zeiher AM, Chavakis T, Dimmeler S. Role of beta2-integrins for homing and neovascularization capacity of endothelial progenitor cells. J Exp Med 2005, 201:63-72. 10.1084/jem.20041402, 2212777, 15623573.
62. Kummer C, Ginsberg MH. New approaches to blockade of α4-integrins, proven therapeutic targets in chronic inflammation. Biochem Pharmacol 2006, 72:1460-1468. 10.1016/j.bcp.2006.06.014, 16870156.
63. Qin G, Ii M, Silver M, Wecker A, Bord E, Ma H, Gavin M, Goukassian DA, Yoon YS, Papayannopoulou T, Asahara T, Kearney M, Thorne T, Curry C, Eaton L, Heyd L, Dinesh D, Kishore R, Zhu Y, Losordo DW. Functional disruption of alpha4 integrin mobilizes bone marrow-derived endothelial progenitors and augments ischemic neovascularization. J Exp Med 2006, 203:153-163. 10.1084/jem.20050459, 2118065, 16401693.
64. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science 1996, 272:60-62. 10.1126/science.272.5258.60, 8600538.
65. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994, 76:301-314. 10.1016/0092-8674(94)90337-9, 7507411.
66. Chan BM, Elices MJ, Murphy E, Hemler ME. Adhesion to vascular cell adhesion molecule 1 and fibronectin. Comparison of alpha 4 beta 1 (VLA-4) and alpha 4 beta 7 on the human B cell line JY. J Biol Chem 1992, 267:8366-8370.
67. Rüegg C, Postigo AA, Sikorski EE, Butcher EC, Pytela R, Erle DJ. Role of integrin alpha 4 beta 7/alpha 4 beta P in lymphocyte adherence to fibronectin and VCAM-1 and in homotypic cell clustering. J Cell Biol 1992, 117:179-189. 10.1083/jcb.117.1.179, 2289398, 1372909.
68. Berlin C, Berg EL, Briskin MJ, Andrew DP, Kilshaw PJ, Holzmann B, Weissman IL, Hamann A, Butcher EC. Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 1993, 74:185-195. 10.1016/0092-8674(93)90305-A, 7687523.
69. Watson AR, Pitchford SC, Reynolds LE, Direkze N, Brittan M, Alison MR, Rankin S, Wright NA, Hodivala-Dilke KM. Deficiency of bone marrow beta3-integrin enhances non-functional neovascularization. J Pathol 2010, 220:435-445.
70. Vajkoczy P, Blum S, Lamparter M, Mailhammer R, Erber R, Engelhardt B, Vestweber D, Hatzopoulos AK. Multistep nature of microvascular recruitment of ex vivo-expanded embryonic endothelial progenitor cells during tumor angiogenesis. J Exp Med 2003, 197:1755-1765. 10.1084/jem.20021659, 2193947, 12810693.
71. Harris ES, McIntyre TM, Prescott SM, Zimmerman GA. The leukocyte integrins. J Biol Chem 2000, 275:23409-23412. 10.1074/jbc.R000004200, 10801898.
72. Jin H, Aiyer A, Su J, Borgstrom P, Stupack D, Friedlander M, Varner J. A homing mechanism for bone marrow-derived progenitor cell recruitment to the neovasculature. J Clin Invest 2006, 116:652-662. 10.1172/JCI24751, 1378185, 16498499.
73. Orschell-Traycoff CM, Hiatt K, Dagher RN, Rice S, Yoder MC, Srour EF. Homing and engraftment potential of Sca-1+lin- cells fractionated on the basis of adhesion molecule expression and position in cell cycle. Blood 2000, 96:1380-1387.
74. Carmona G, Chavakis E, Koehl U, Zeiher AM, Dimmeler S. Activation of Epac stimulates integrin-dependent homing of progenitor cells. Blood 2008, 111:2640-2646. 10.1182/blood-2007-04-086231, 18032709.
75. Pytela R, Pierschbacher MD, Ruoslahti E. Identification and isolation of a 140 kd cell surface glycoprotein with properties expected of a fibronectin receptor. Cell 1985, 40:191-198. 10.1016/0092-8674(85)90322-8, 3155652.
76. Roman J, LaChance RM, Broekelmann TJ, Kennedy CJ, Wayner EA, Carter WG, McDonald JA. The fibronectin receptor is organized by extracellular matrix fibronectin: implications for oncogenic transformation and for cell recognition of fibronectin matrices. J Cell Biol 1989, 108:2529-2543. 10.1083/jcb.108.6.2529, 2115589, 2472410.
77. Akiyama SK, Yamada SS, Chen WT, Yamada KM. Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization. J Cell Biol 1989, 109:863-875. 10.1083/jcb.109.2.863, 2115712, 2527241.
78. Giancotti FG, Ruoslahti E. Elevated levels of the alpha 5 beta 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell 1990, 60:849-859. 10.1016/0092-8674(90)90098-Y, 2155708.
79. Werb Z, Tremble PM, Behrendtsen O, Crowley E, Damsky CH. Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J Cell Biol 1989, 109:877-889. 10.1083/jcb.109.2.877, 2115739, 2547805.
80. Yang JT, Rayburn H, Hynes RO. Embryonic mesodermal defects in alpha 5 integrin-deficient mice. Development 1993, 119:1093-1105.
81. Bauters C, Marotte F, Hamon M, Oliviéro P, Farhadian F, Robert V, Samuel JL, Rappaport L. Accumulation of fetal fibronectin mRNAs after balloon denudation of rabbit arteries. Circulation 1995, 92:904-911.
82. Angelos MG, Brown MA, Satterwhite LL, Levering VW, Shaked NT, Truskey GA. Dynamic adhesion of umbilical cord blood endothelial progenitor cells under laminar shear stress. Biophys J 2010, 99:3545-3554. 10.1016/j.bpj.2010.10.004, 2998604, 21112278.
83. Wary KK, Vogel SM, Garrean S, Zhao YD, Malik AB. Requirement of alpha(4)beta(1) and alpha(5)beta(1) integrin expression in bone-marrow-derived progenitor cells in preventing endotoxin-induced lung vascular injury and edema in mice. Stem Cells 2009, 27:3112-3120.
84. Georges-Labouesse E, Messaddeq N, Yehia G, Cadalbert L, Dierich A, Le Meur M. Absence of integrin alpha 6 leads to epidermolysis bullosa and neonatal death in mice. Nat Genet 1996, 13:370-373. 10.1038/ng0796-370, 8673141.
85. Chabut D, Fischer AM, Colliec-Jouault S, Laurendeau I, Matou S, Le Bonniec B, Helley D. Low molecular weight fucoidan and heparin enhance the basic fibroblast growth factor-induced tube formation of endothelial cells through heparan sulfate-dependent alpha6 overexpression. Mol Pharmacol 2003, 64:696-702. 10.1124/mol.64.3.696, 12920206.
86. Qian H, Tryggvason K, Jacobsen SE, Ekblom M. Contribution of alpha6 integrins to hematopoietic stem and progenitor cell homing to bone marrow and collaboration with alpha4 integrins. Blood 2006, 107:3503-3510. 10.1182/blood-2005-10-3932, 16439681.
87. Smadja DM, Bièche I, Helley D, Laurendeau I, Simonin G, Muller L, Aiach M, Gaussem P. Increased VEGFR2 expression during human late endothelial progenitor cells expansion enhances in vitro angiogenesis with up-regulation of integrin alpha(6). J Cell Mol Med 2007, 11:1149-1161. 10.1111/j.1582-4934.2007.00090.x, 17979890.
88. Kokubo T, Uchida H, Choi ET. Integrin alpha(v)beta(3) as a target in the prevention of neointimal hyperplasia. J Vasc Surg 2007, 45(Suppl A):A33-A38. 1939972, 17544022.
89. Di Santo S, Diehm N, Ortmann J, Völzmann J, Yang Z, Keo HH, Baumgartner I, Kalka C. Oxidized low density lipoprotein impairs endothelial progenitor cell function by downregulation of E-selectin and integrin alpha(v)beta5. Biochem Biophys Res Commun 2008, 373:528-532. 10.1016/j.bbrc.2008.06.066, 18590706.
90. Chavakis E, Hain A, Vinci M, Carmona G, Bianchi ME, Vajkoczy P, Zeiher AM, Chavakis T, Dimmeler S. High-mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells. Circ Res 2007, 100:204-212. 10.1161/01.RES.0000257774.55970.f4, 17218606.
91. Hur J, Yoon CH, Lee CS, Kim TY, Oh IY, Park KW, Kim JH, Lee HS, Kang HJ, Chae IH, Oh BH, Park YB, Kim HS. Akt is a key modulator of endothelial progenitor cell trafficking in ischemic muscle. Stem Cells 2007, 25:1769-1778. 10.1634/stemcells.2006-0385, 17412896.
92. Hanjaya-Putra D, Yee J, Ceci D, Truitt R, Yee D, Gerecht S. Vascular endothelial growth factor and substrate mechanics regulate in vitro tubulogenesis of endothelial progenitor cells. J Cell Mol Med 2010, 14:2436-2447. 10.1111/j.1582-4934.2009.00981.x, 19968735.
93. Yang JT, Rayburn H, Hynes RO. Embryonic mesodermal defects in alpha 5 integrin-deficient mice. Development 1993, 119:1093-1105.
94. George EL, Baldwin HS, Hynes RO. Fibronectins are essential for heart and blood vessel morphogenesis but are dispensable for initial specification of precursor cells. Blood 1997, 90:3073-3081.
95. Goh KL, Yang JT, Hynes RO. Mesodermal defects and cranial neural crest apoptosis in alpha5 integrin-null embryos. Development 1997, 124:4309-4319.
96. Wijelath ES, Rahman S, Namekata M, Murray J, Nishimura T, Mostafavi-Pour Z, Patel Y, Suda Y, Humphries MJ, Sobel M. Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain: enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism. Circ Res 2006, 99:853-860. 10.1161/01.RES.0000246849.17887.66, 3175430, 17008606.
97. Wijelath ES, Murray J, Rahman S, Patel Y, Ishida A, Strand K, Aziz S, Cardona C, Hammond WP, Savidge GF, Rafii S, Sobel M. Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity. Circ Res 2002, 91:25-31. 10.1161/01.RES.0000026420.22406.79, 12114318.
98. Tian F, Liang PH, Li L-Y. Inhibition of endothelial progenitor cell differentiation by VEGI. Blood 2009, 113:5352-5360. 10.1182/blood-2008-08-173773, 2686197, 19329781.
99. Leifheit-Nestler M, Conrad G, Heida NM, Limbourg A, Limbourg FP, Seidler T, Schroeter MR, Hasenfuss G, Konstantinides S, Schäfer K. Overexpression of integrin beta 5 enhances the paracrine properties of circulating angiogenic cells via Src kinase-mediated activation of STAT3. Arterioscler Thromb Vasc Biol 2010, 30:1398-1406. 10.1161/ATVBAHA.110.206086, 20431064.
100. Barsotti MC, Magera A, Armani C, Chiellini F, Felice F, Dinucci D, Piras AM, Minnocci A, Solaro R, Soldani G, Balbarini A, Di Stefano R. Fibrin acts as biomimetic niche inducing both differentiation and stem cell marker expression of early human endothelial progenitor cells. Cell Prolif 2011, 44:33-48. 10.1111/j.1365-2184.2010.00715.x, 21199008.
101. Assmus B, Fischer-Rasokat U, Honold J, Seeger FH, Fichtlscherer S, Tonn T, Seifried E, Schächinger V, Dimmeler S, Zeiher AM. Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE- CHD Registry. Circ Res 2007, 100:1234-1241. 10.1161/01.RES.0000264508.47717.6b, 17379833.
102. Wang XX, Zhang FR, Shang YP, Zhu JH, Xie XD, Tao QM, Zhu JH, Chen JZ. Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial. J Am Coll Cardiol 2007, 49:1566-1571. 10.1016/j.jacc.2006.12.037, 17418297.
103. Assmus B, Honold J, Schächinger V, Britten MB, Fischer-Rasokat U, Lehmann R, Teupe C, Pistorius K, Martin H, Abolmaali ND, Tonn T, Dimmeler S, Zeiher AM. Transcoronary transplantation of progenitor cells after myocardial infarction. N Eng J Med 2006, 355:1222-1232.
104. Erbs S, Linke A, Adams V, Lenk K, Thiele H, Diederich KW, Emmrich F, Kluge R, Kendziorra K, Sabri O, Schuler G, Hambrecht R. Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study. Circ Res 2005, 97:756-762. 10.1161/01.RES.0000185811.71306.8b, 16151021.
105. Katritsis DG, Sotiropoulou PA, Karvouni E, Karabinos I, Korovesis S, Perez SA, Voridis EM, Papamichail M. Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium. Cathet Cardiovasc Interv 2005, 65:321-329.
106. Schächinger V, Assmus B, Britten MB, Honold J, Lehmann R, Teupe C, Abolmaali ND, Vogl TJ, Hofmann WK, Martin H, Dimmeler S, Zeiher AM. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI trial. J Am Coll Cardiol 2004, 44:1690-1699. 10.1016/j.jacc.2004.08.014, 15489105.
107. Lara-Hernandez R, Lozano-Vilardell P, Blanes P, Torreguitart-Mirada N, Galmés A, Besalduch J. Safety and efficacy of therapeutic angiogenesis as a novel treatment in patients with critical limb ischemia. Ann Vasc Surg 2010, 24:287-294. 10.1016/j.avsg.2009.10.012, 20142004.
108. Chong E, Poh KK, Liang S, Lee RC, Low A, Teo SG, Tan HC. Two-year clinical registry follow-up of endothelial progenitor cell capture stent versus sirolimus-eluting bioabsorbable polymer-coated stent versus bare metal stents in patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction. J Interv Cardiol 2010, 23:101-108. 10.1111/j.1540-8183.2010.00534.x, 20236214.
109. Bystroň M, Cervinka P, Spaček R, Kvašňák M, Jakabčin J, Cervinková M, Kala P, Widimský P. Randomized comparison of endothelial progenitor cells capture stent versus cobalt-chromium stent for treatment of st-elevation myocardial infarction six-month clinical, angiographic and IVUS follow-up. Cathet Cardiovasc Interv 2010, 76:627-631.
110. Losordo DW, Henry TD, Davidson C, Sup Lee J, Costa MA, Bass T, Mendelsohn F, Fortuin FD, Pepine CJ, Traverse JH, Amrani D, Ewenstein BM, Riedel N, Story K, Barker K, Povsic TJ, Harrington RA, Schatz RA. Intramyocardial, autologous CD34+ cell therapy for refractory angina. Circ Res 2011, 109:428-436. 10.1161/CIRCRESAHA.111.245993, 3190575, 21737787.
111. Napoli C, Hayashi T, Cacciatore F, Casamassimi A, Casini C, Al-Omran M, Ignarro LJ. Endothelial progenitor cells as therapeutic agents in the microcirculation: an update. Atherosclerosis 2011, 215:9-22. 10.1016/j.atherosclerosis.2010.10.039, 21126740.
112. Aicher A, Brenner W, Zuhayra M, Badorff C, Massoudi S, Assmus B, Eckey T, Henze E, Zeiher AM, Dimmeler S. Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 2003, 107:2134-2139. 10.1161/01.CIR.0000062649.63838.C9, 12695305.
113. Müller-Ehmsen J, Krausgrill B, Burst V, Schenk K, Neisen UC, Fries JW, Fleischmann BK, Hescheler J, Schwinger RH. Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction. J Mol Cell Cardiol 2006, 41:876-884. 10.1016/j.yjmcc.2006.07.023, 16973174.
114. Bonaros N, Rauf R, Schachner T, Laufer G, Kocher A. Enhanced cell therapy for ischemic heart disease. Transplantation 2008, 86:1151-1160. 10.1097/TP.0b013e3181880f9e, 19005393.
115. Critser PJ, Kreger ST, Voytik-Harbin SL, Yoder MC. Collagen matrix physical properties modulate endothelial colony forming cell-derived vessels in vivo. Microvas Res 2010, 80:23-30.
116. Kuraitis D, Hou C, Zhang Y, Vulesevic B, Sofrenovic T, McKee D, Sharif Z, Ruel M, Suuronen EJ. Ex vivo generation of a highly potent population of circulating angiogenic cells using a collagen matrix. J Mol Cell Cardiol 2011, 51:187-197. 10.1016/j.yjmcc.2011.04.011, 21569777.
117. Bleiziffer O, Hammon M, Naschberger E, Lipnik K, Arkudas A, Rath S, Pryymachuk G, Beier JP, Stürzl M, Horch RE, Kneser U. Endothelial progenitor cells are integrated in newly formed capillaries and alter adjacent fibrovascular tissue after subcutaneous implantation in a fibrin matrix. J Cell Mol Med 2011, 15:2452-2461. 10.1111/j.1582-4934.2010.01247.x, 21199325.
118. Ferreira LS, Gerecht S, Fuller J, Shieh HF, Vunjak-Novakovic G, Langer R. Bioactive hydrogel scaffolds for controllable vascular differentiation of human embryonic stem cells. Biomaterials 2007, 28:2706-2717. 10.1016/j.biomaterials.2007.01.021, 1903348, 17346788.
119. Zamora PO, Eshima D, Graham D, Shattuck L, Rhodes BA. Biological distribution of 99mTc-labeled YIGSR and IKVAV laminin peptides in rodents: 99mTc-IKVAV peptide localizes to the lung. Biochim Biophys Acta 1993, 1182:197-204.
120. Tsilibary EC, Reger LA, Vogel AM, Koliakos GG, Anderson SS, Charonis AS, Alegre JN, Furcht LT. Identification of a multifunctional, cell-binding peptide sequence from the a1(NC1) of type IV collagen. J Cell Biol 1990, 111:1583-1591. 10.1083/jcb.111.4.1583, 2116235, 2211826.
121. Yamamoto M, Yamamoto K, Noumura Y. Type I collagen promotes modulation of cultured rabbit arterial smooth muscle cells from a contractile to a synthetic phenotype. Exp Cell Res 1993, 204:121-129. 10.1006/excr.1993.1016, 8416790.
122. Hocking DC, Sottile J, McKeown-Longo PJ. Activation of distinct a5b1-mediated signaling pathways by fibronectin's cell adhesion and matrix assembly domains. J Cell Biol 1998, 141:241-253. 10.1083/jcb.141.1.241, 2132721, 9531562.
123. Alobaid N, Salacinski HJ, Sales KM, Ramesh B, Kannan RY, Hamilton G, Seifalian AM. Nanocomposite containing bioactive peptides promote endothelialisation by circulating progenitor cells: an in vitro evaluation. Eur J Vasc Endovasc Surg 2006, 32:76-83. 10.1016/j.ejvs.2005.11.034, 16466940.
124. Blindt R, Vogt F, Astafieva I, Fach C, Hristov M, Krott N, Seitz B, Kapurniotu A, Kwok C, Dewor M, Bosserhoff AK, Bernhagen J, Hanrath P, Hoffmann R, Weber C. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells. J Am Coll Cardiol 2006, 47:1786-1795. 10.1016/j.jacc.2005.11.081, 16682302.
125. Kim KL, Han DK, Park K, Song SH, Kim JY, Kim JM, Ki HY, Yie SW, Roh CR, Jeon ES, Kim DK, Suh W. Enhanced dermal wound neovascularization by targeted delivery of endothelial progenitor cells using an RGD-g-PLLA scaffold. Biomaterials 2009, 30:3742-3748. 10.1016/j.biomaterials.2009.03.053, 19394079.
126. Fusenig N, Marmé D. Tumor Angiogenesis: Basic Mechanisms and Cancer Therapy. Springer 2008, Chapter 17.